Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Navidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Key Component of the Company’s Cancer Immunotherapy Pipeline: https://mms.businesswire.com/media/20191107006076/en/389794/5/navidea_cmyk.jpg
Navidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Key Component of the Company’s Cancer Immunotherapy Pipeline


Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today

Chevron Finalizes Acquisition of Beyond6 CNG Fueling Networkhttp://intelligents.wpengine.netdna-cdn.com/wp-content/uploads/2011/04/chevron-corporation-logo.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11090/chevron-corporation-logo.png
Chevron Finalizes Acquisition of Beyond6 CNG Fueling Network


Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE: CVX), today closed its previously announced acquisition of full ownership of Beyond6, LLC and its nationwide network of compressed

Diodes Incorporated to Present at the Needham Growth Conference on January 12: https://mms.businesswire.com/media/20200323005671/en/218867/5/Diodes_logo_%28r%29_small.jpg
Diodes Incorporated to Present at the Needham Growth Conference on January 12


Diodes Incorporated (Nasdaq: DIOD), today announced Brett Whitmire, Chief Financial Officer; Emily Yang, Senior Vice President of Worldwide Sales and Marketing; and Gurmeet Dhaliwal, Director of

Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference: https://mms.businesswire.com/media/20211102005274/en/922183/5/Logo_2020.jpg
Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference


Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced

Premier Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023


Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in the 41st Annual J.P. Morgan

RPM Declares Quarterly Dividend: https://mms.businesswire.com/media/20200903005685/en/818366/5/Rust-Oleum-logo+%28002%29.jpg
RPM Declares Quarterly Dividend


RPM International Inc. (NYSE: RPM) today announced that its board of directors declared a regular quarterly cash dividend of $0.42 per share, payable on January 31, 2023, to stockholders of record

West Virginia American Water Receives Approval of 2023 Distribution System Improvement Charge: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24231/300px-American_Water_%28company%29_Logo.svg.png
West Virginia American Water Receives Approval of 2023 Distribution System Improvement Charge


In an order entered today, the Public Service Commission of West Virginia (PSC) approved a joint agreement reached last month in West Virginia American Water’s request for approval of its 2023

Helmerich & Payne, Inc. To Participate in Conferences in January 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24508/Helmerich___Payne_logo.png
Helmerich & Payne, Inc. To Participate in Conferences in January 2023


Helmerich & Payne, Inc. (NYSE: HP) today announced that John Lindsay, President and Chief Executive Officer; Mark Smith, Senior Vice President and Chief Financial Officer; Mike Lennox, Senior Vice

GAMCO Expects to Report Diluted EPS for 2022 of $2.37 to $2.47 Per Share: https://mms.businesswire.com/media/20201019005535/en/831358/5/CBS+logo.jpg
GAMCO Expects to Report Diluted EPS for 2022 of $2.37 to $2.47 Per Share


GAMCO Investors, Inc. (“GAMCO”) (OTCQX:GAMI) announced today that it expects to report calendar 2022 diluted earnings in the range of $2.37 to $2.47 per share versus $2.73 per share for 2021.

Trex Company Announces Sale of Its Commercial Products Business: https://mms.businesswire.com/media/20200121005014/en/553939/5/TREX0406_Logo_Resize_L1rd_10_2016.jpg
Trex Company Announces Sale of Its Commercial Products Business


Trex Company, Inc. (NYSE:TREX), the world’s #1 brand of high-performance, low-maintenance and eco-friendly composite decking, railing and outdoor living products today announced the sale of

The First Bancshares, Inc. and Heritage Southeast Bancorporation, Inc. Announce Receipt of Shareholder Approvals for Merger: https://mms.businesswire.com/media/20191101005101/en/60698/5/Logo_Holding.jpg
The First Bancshares, Inc. and Heritage Southeast Bancorporation, Inc. Announce Receipt of Shareholder Approvals for Merger


The First Bancshares, Inc. (NASDAQ: FBMS) (“First Bancshares” or the “Company”), the holding company for The First Bank, and Heritage Southeast Bancorporation, Inc. (OTC: HSBI) (“HSBI”), the

Intevac Announces Completion of Joint Development Agreement for TRIO™: https://mms.businesswire.com/media/20191101005110/en/497226/5/IVAC_LOGO_Horizontal_.jpg
Intevac Announces Completion of Joint Development Agreement for TRIO™


Intevac, Inc. (Nasdaq:IVAC, “Intevac” or “the Company”), a leading supplier of thin-film processing systems, today announced it has signed a joint development agreement with a major provider of

Vistagen Advances Intellectual Property Program to Expand Patent Protection for PH94B to Include Treatment of Adjustment Disorder: https://mms.businesswire.com/media/20220908005443/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg
Vistagen Advances Intellectual Property Program to Expand Patent Protection for PH94B to Include Treatment of Adjustment Disorder


Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous

Pioneer Natural Resources to Present at Goldman Sachs Global Energy and Clean Technology Conference: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24709/Pioneer_Natural_Resources_logo.png
Pioneer Natural Resources to Present at Goldman Sachs Global Energy and Clean Technology Conference


Pioneer Natural Resources Company (NYSE:PXD) today announced that Chief Executive Officer, Scott Sheffield, will present at the Goldman Sachs Global Energy and Clean Technology Conference on

Ault Alpha Has Purchased 50 Million Shares of Common Stock of BitNile Holdings, Inc.: https://mms.businesswire.com/media/20220512005443/en/1267458/5/Bitnile_Logo_%28300ppi%29.jpg
Ault Alpha Has Purchased 50 Million Shares of Common Stock of BitNile Holdings, Inc.


BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”), announced today that its related party, Ault Alpha, LP (“Ault Alpha”), has purchased an

Jack in the Box to Present at 2023 ICR Conference on Monday, January 9th: https://mms.businesswire.com/media/20200729005173/en/808770/5/Jack_in_the_Box_Primary_Logo.jpg
Jack in the Box to Present at 2023 ICR Conference on Monday, January 9th


Jack in the Box, Inc. (NASDAQ: JACK) announces the following event:


What:


Jack in the Box presentation at the 2023 ICR Conference in Orlando, FL
Darin Harris, CEO

 


When:

Guess?, Inc. Announces Participation at the ICR Conference 2023: https://mms.businesswire.com/media/20191204005915/en/760670/5/GUESS_ECO_TRIANGLE.jpg
Guess?, Inc. Announces Participation at the ICR Conference 2023


Guess?, Inc. (NYSE: GES) announced today that the Company will be participating in a fireside chat at the ICR Conference 2023 on Monday, January 9, 2023 at 8:30 a.m. Eastern Time. The Company will

Discover Financial Services Announces Fourth Quarter 2022 Earnings Release on January 18, 2023, and Conference Call on January 19, 2023: https://mms.businesswire.com/media/20191118005067/en/756953/5/Discover_NHL_092019v2_lock_up_2020.jpg
Discover Financial Services Announces Fourth Quarter 2022 Earnings Release on January 18, 2023, and Conference Call on January 19, 2023


Discover Financial Services (NYSE: DFS) plans to report its fourth quarter 2022 results after the market closes on Wednesday, January 18, 2023. The earnings release will be available through

Redfin Reports Homes Linger on the Market as Buyers Take Their Time: https://mms.businesswire.com/media/20221109005873/en/1407505/5/Redfin_Standard_Web_Logo.jpg
Redfin Reports Homes Linger on the Market as Buyers Take Their Time


(NASDAQ: RDFN) —The total number of homes for sale rose 18% from a year earlier during the four weeks ending December 25, the biggest increase since at least 2015, according to a new report from

Oceaneering to Participate at the 2023 Goldman Sachs Global Energy and Clean Technology Conference: https://mms.businesswire.com/media/20220413005665/en/1420206/5/Oceaneering-Logo-blue-PMS-302-C.jpg
Oceaneering to Participate at the 2023 Goldman Sachs Global Energy and Clean Technology Conference


Oceaneering International, Inc. ("Oceaneering") (NYSE:OII) announced today that Senior Vice President and Chief Financial Officer Alan R. Curtis and Vice President, Corporate Development and

Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidatehttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate


Pfizer Inc. (NYSE: PFE) today announced positive top-line results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene elaparvovec, an investigational gene therapy, for the

Atkore Inc. Announces Retirement of William VanArsdale from Board of Directors: https://mms.businesswire.com/media/20200204005248/en/770908/5/Atkore_Logo_2C_PMS_Horiz_%282%29_highres.jpg
Atkore Inc. Announces Retirement of William VanArsdale from Board of Directors


Atkore Inc. (“Atkore”), today announced that William (Bill) R. VanArsdale is retiring from the Atkore Board of Directors for personal reasons, effective Wednesday, December 28, 2022.



Mr

Alcoa Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call: https://mms.businesswire.com/media/20191121005110/en/566032/5/Alcoa_logo_horizontal_blue_%282%29.jpg
Alcoa Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call


Alcoa Corporation plans to announce its fourth quarter and full year 2022 financial results on Wednesday, January 18, 2023, after the close of trading on the New York Stock Exchange.



The press

Fluor Announces Full Redemption of Its 1.750% Senior Notes Due 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24458/Logo_FLUOR.svg.png
Fluor Announces Full Redemption of Its 1.750% Senior Notes Due 2023


Fluor Corporation (NYSE: FLR) (the “Company” or “Fluor”) announced today that it will redeem in full the entire outstanding €128,970,000 aggregate principal amount of its 1.750% Senior Notes due

New Mountain Finance Corporation Extends Stock Repurchase Program: https://mms.businesswire.com/media/20220225005566/en/817636/5/NMFC_Header_Logo.jpg
New Mountain Finance Corporation Extends Stock Repurchase Program


New Mountain Finance Corporation (NASDAQ: NMFC) (“NMFC” or “the Company”) today announced that on December 22, 2022 its board of directors authorized an extension of a previously established stock